Orion
Laura Lassila currently serves as an Operational Excellence Specialist at Orion Corporation since November 2022, following a role as a Research Assistant in the same field. Prior to this, Laura gained experience as a trainee at Brinter from May 2022 to August 2022. Laura is pursuing a degree in Biotechnology and Biomedical Engineering at Tampere University, with an expected graduation date in June 2024.
This person is not in any teams
This person is not in any offices
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.